Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carlsen

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|March 29, 2017
Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A InhibitorsLong V Pham, Santseharay Ramirez, Thomas H R Carlsen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 13, 2022
Oral vaccination using microdevices to deliver α-GalCer adjuvanted vaccine afford a mucosal immune responsePhilip H R Carlsen, Rolf Bech Kjeldsen, Gabriel K Pedersen, et al.
Plos Pathogens|June 2, 2012
Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systemsTroels K H Scheel, Jannick Prentoe, Thomas H R Carlsen, et al.
The Journal of the American Osteopathic Association|April 17, 2009
Interexpert agreement on diagnosis of bacteriuria and urinary tract infection in hospitalized older adultsJen-Tzer Gau, Mesfin R Shibeshi, I-Ju Lu, et al.
The Journal of Rheumatology|July 1, 1994
Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associationsD W Templin, G S Boyer, A P Lanier, et al.
Plos One|May 14, 2013
Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcomeJannie Pedersen, Tanja B Jensen, Thomas H R Carlsen, et al.
Journal of Virology|December 24, 2010
Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutationsTroels K H Scheel, Judith M Gottwein, Thomas H R Carlsen, et al.
Gastroenterology|December 25, 2017
Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape VariantsJudith M Gottwein, Long V Pham, Lotte S Mikkelsen, et al.
Scientific Reports|March 29, 2019
A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccineChristoph M Janitzek, Julianne Peabody, Susan Thrane, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3aThomas H R Carlsen, Jannie Pedersen, Jannick C Prentoe, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|March 29, 2017
Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A InhibitorsLong V Pham, Santseharay Ramirez, Thomas H R Carlsen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 13, 2022
Oral vaccination using microdevices to deliver α-GalCer adjuvanted vaccine afford a mucosal immune responsePhilip H R Carlsen, Rolf Bech Kjeldsen, Gabriel K Pedersen, et al.
Plos Pathogens|June 2, 2012
Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systemsTroels K H Scheel, Jannick Prentoe, Thomas H R Carlsen, et al.
The Journal of the American Osteopathic Association|April 17, 2009
Interexpert agreement on diagnosis of bacteriuria and urinary tract infection in hospitalized older adultsJen-Tzer Gau, Mesfin R Shibeshi, I-Ju Lu, et al.
The Journal of Rheumatology|July 1, 1994
Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associationsD W Templin, G S Boyer, A P Lanier, et al.
Plos One|May 14, 2013
Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcomeJannie Pedersen, Tanja B Jensen, Thomas H R Carlsen, et al.
Journal of Virology|December 24, 2010
Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutationsTroels K H Scheel, Judith M Gottwein, Thomas H R Carlsen, et al.
Gastroenterology|December 25, 2017
Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape VariantsJudith M Gottwein, Long V Pham, Lotte S Mikkelsen, et al.
Scientific Reports|March 29, 2019
A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccineChristoph M Janitzek, Julianne Peabody, Susan Thrane, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3aThomas H R Carlsen, Jannie Pedersen, Jannick C Prentoe, et al.
Pageof 3